Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Noninvasive Neuromodulation in the Management of Post-COVID Musculoskeletal Pain — Stella

Home/COVID-19/Noninvasive Neuromodulation in the Management of Post-COVID Musculoskeletal Pain

View on ClinicalTrials.gov

Recruiting

Back to COVID-19 trials

Noninvasive Neuromodulation in the Management of Post-COVID Musculoskeletal Pain

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Spain

Centro Investigación Fisioterapia y Dolor, Alcalá de Henares, Madrid

Key details

Sponsor

University of Alcala

Enrollment target

~40 participants

Started

December 2024

Primary completion

October 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 65 Years

Last updated June 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.